Lupin Limited has informed the Exchange about press release dated 03-Mar-2022 titled Lupin Receives Approval from U.S. FDA for Efinaconazole Topical Solution.
Press Release Mar 03 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Mar 01 2022
- Press Release Feb 23 2022
- Press Release Feb 17 2022
- Press Release Feb 09 2022
- Press Release Feb 08 2022
Later from Lupin
- Press Release Mar 07 2022
- Press Release Mar 09 2022
- Press Release Mar 10 2022
- Press Release Mar 11 2022
- Press Release Mar 24 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin